Sharing the trial and error learned lessons of a MS spouse caregiver / carer about family, home care, and transition to the care facility era from 23 years of living with Multiple Sclerosis as a family ... a ‘warts and all’ picture of living with MS.
If you or I sold something that was not what it was supposed to be, what would happen to us?
Yet for players in the Multiple Sclerosis stock market, money can be made win, loose or draw.
It makes you wonder …
Not long ago Acorda sold “overseas” rights:
“… Acorda has had operating losses since inception … In order to sustain operations beyond 2010, Acorda sold overseas rights to Fampridine SR to Biogen Idec Inc. in July of this year and received an upfront payment of $110 million …” (Will Acorda Walk The Talk?)